Tumor necrosis factor and tuberculosis

Journal of Investigative Dermatology Symposium Proceedings

Volumn 12, Issue 1, 2007, Pages 22-25

  Lin, Philana Ling ^a,b   Plessner, Hillarie L ^b   Voitenok, Nikolai N ^c   Flynn, JoAnne L ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Fund for Molecular Hematology and Immunology   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CHEMOKINE; ETANERCEPT; HYBRID PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ARTICLE; CROHN DISEASE; EXPERIMENTAL MODEL; GRANULOMA; HUMAN; MONKEY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOLOGY; PRIMATE; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; TUBERCULOSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; CHEMOKINES; DISEASE MODELS, ANIMAL; GRANULOMA; HUMANS; MACACA FASCICULARIS; MICE; NEUTRALIZATION TESTS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34248523386     PISSN: 10870024     EISSN: 15291774     Source Type: Journal    
DOI: 10.1038/sj.jidsymp.5650027     Document Type: Article

References (29)

1. Algood HM, Flynn JL (2004) CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J Immunol 173:3287-96
2. Algood HM, Lin PL, Yankura D, Jones A, Chan J, Flynn JL (2004) TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection. J Immunol 172:6846-57
3. Bean AGD, Roach DR, Briscoe H, France MP, Korner H, Sedgwick JD et al. (1999) Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 162:3504-11
4. Bhatt K, Hickman SP, Salgame P (2004) Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis. J Immunol 172:2748-51
5. Bodnar KA, Serbina NV, Flynn JL (2001) Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect Immun 69:800-9
6. Capuano SVI, Croix DA, Pawar S, Zinovik A, Myers A, Lin PL et al. (2003) Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect Immun 71:5831-44
7. Chen M, Gan H, Remold HG (2006) A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J Immunol 176:3707-16
8. Flesch IEA, Kaufmann SHE (1990) Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect Immun 58:2675-7
9. Flynn JL, Chan J (2001) Immunology of tuberculosis. Annual Review of Immunology 19:93-129
10. Flynn JL, Chan J (2005) What's good for the host is good for the bug. Trends Microbiol 13:98-102
11. Flynn JL, Cooper A, Bishai WR (2005) Animal models of tuberculosis. Taken from: Tuberculosis and the Tubercle Bacillus. (Cole ST, Eisenach KD, McMurray DN, Jacobs WR, eds), Washington, DC: ASM Press, 547-60
12. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ et al. (1995) Tumor necrosis factor-α is required in the protective immune response against M* tuberculosis in mice. Immunity 2:561-72
13. Fuller CL, Flynn JL, Reinhart TA (2003) In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis. Infect Immun 71:7023-34
14. Gan H, He X, Duan L, Mirabile-Levens E, Kornfeld H, Remold HG (2005) Enhancement of antimycobacterial activity of macrophages by stabilization of inner mitochondrial membrane potential. J Infect Dis 191:1292-300
15. Garay SM (2004) Pulmonary tuberculosis. Taken from: Tuberculosis, (WN Rom SMG ed), 2nd edn Philadelphia: Lippincott Williams & Wilkins, 345-94
16. Johnson CM, Cooper AM, Frank AA, Orme IM (1998) Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene. Infect Immun 66:1666-70
17. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD et al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098-104
18. Keane J, Remold HG, Kornfeld H (2000) Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol 164:2016-20
19. Lazarevic V, Myers AJ, Scanga CA, Flynn JL (2003) CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. Immunity 19:823-35
20. Mohan VP, Scanga CA, Yu K, Scott HM, Tanaka KE, Tsang E et al. (2001) Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 69:1847-55
21. Russell DG (2001) Mycobacterium tuberculosis: here today, and here tomorrow. Nat Rev Mol Cell Biol 2:569-77
22. Scallon B, Cai A, Solowski N, Rosenberg A, Song XY, Shealy D et al. (2002) Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 301:418-26
23. Schreiber T, Ehlers S, Aly S, Holscher A, Hartmann S, Lipp M et al. (2006) Selectin ligand-independent priming and maintenance of T cell immunity during airborne tuberculosis. J Immunol 176:1131-40
24. Seiler P, Aichele P, Bandermann S, Hauser AE, Lu B, Gerard NP et al. (2003) Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. Eur J Immunol 33:2676-86
25. Serbina NV, Flynn JL (1999) Early emergence of CD8+ T cells primed for production of Type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect Immun 67:3980-8
26. Song XY, Fox F, Gallo MA, Rosenberg A, Jordan R, Shealy D et al. (2002) Effects of 2 different anti-tumor necrosis factor-alpha agents in a primate model of subcutaneous abscess formation. J Infect Dis 185:204-13
27. Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, Froelich CJ et al. (1998) An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:121-5
28. Vandiviere HM, Loring WE, Melvin I, Willis S (1956) The treated pulmonary lesion and its tubercle bacillus. II The death and resurrection. Am J Med Sci 232:30-7
29. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38:1261-5